Improving Terminology to Describe Coronary Artery Procedures: JACC Review Topic of the Week
Related Experiment Video
Updated: Oct 23, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Torsten Doenst1, Robert O Bonow2, Deepak L Bhatt3
1Department of Cardiothoracic Surgery, Jena University Hospital, Friedrich-Schiller-University of Jena, Jena, Germany.
Insights
The term "myocardial revascularization" for coronary artery disease (CAD) treatments like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) is misleading. A descriptive term, "invasive treatment," better reflects the complex benefits of PCI and CABG.
Area of Science:
- Cardiology
- Medical Terminology
- Clinical Practice
Background:
- Coronary artery disease (CAD) management includes medical therapy, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG).
- PCI and CABG are often grouped under the term "myocardial revascularization."
- This umbrella term may oversimplify the distinct physiological effects of these invasive procedures.
Purpose of the Study:
- To critically evaluate the appropriateness of the term "myocardial revascularization" for PCI and CABG.
- To propose an alternative, more descriptive terminology for invasive CAD treatments.
- To enhance clinical decision-making and guide future research in cardiovascular interventions.
Main Methods:
- Review of current evidence on the mechanisms and effects of PCI and CABG.
- Analysis of the implications of terminology on understanding treatment outcomes.
- Comparative assessment of "myocardial revascularization" versus descriptive terms.
Main Results:
- The term "myocardial revascularization" inaccurately suggests a singular effect (restoring blood flow to ischemic tissue).
- It obscures crucial mechanisms like improved coronary flow without ischemia, reperfusion during ischemia, and prevention of myocardial infarction.
- PCI and CABG encompass a broader range of therapeutic benefits than implied by "myocardial revascularization."
Conclusions:
- The term "myocardial revascularization" is inappropriate for describing PCI and CABG.
- A purely descriptive terminology, such as "invasive treatment by PCI or CABG," is recommended.
- Adopting precise terminology can improve clinical decision-making and inform future trial designs for CAD interventions.
Abstract:
Coronary artery disease (CAD) is treated with medical therapy with or without percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The latter 2 options are commonly referred to as "myocardial revascularization" procedures. We reason that this term is inappropriate because it is suggestive of a single treatment effect of PCI and CABG (ie, the reestablishment of blood flow to ischemic myocardium) and obscures key mechanisms, such as the improvement in coronary flow capability in the absence of ongoing ischemia, the reperfusion in the presence of ischemia, and the prevention of myocardial infarction from CAD progression. We review the current evidence on the topic and suggest the use of a purely descriptive terminology ("invasive treatment by PCI or CABG") which has the potential to improve clinical decision making and guide future trial design.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

